706 related articles for article (PubMed ID: 25338637)
1. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
2. NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression.
Zheng J; Li Y; Yang J; Liu Q; Shi M; Zhang R; Shi H; Ren Q; Ma J; Guo H; Tao Y; Xue Y; Jiang N; Yao L; Liu W
BMC Cancer; 2011 Jun; 11():251:1-9. PubMed ID: 21676268
[TBL] [Abstract][Full Text] [Related]
3. Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Guo X; Xiong L; Yu L; Li R; Wang Z; Ren B; Dong J; Li B; Wang D
Diagn Pathol; 2014 Sep; 9():175. PubMed ID: 25230759
[TBL] [Abstract][Full Text] [Related]
4. Reduced N-Myc downstream-regulated gene 2 expression is associated with CD24 upregulation and poor prognosis in patients with lung adenocarcinoma.
Wang H; Wang W; Wang X; Cai K; Wu H; Ju Q; Huang Z; Gao X
Med Oncol; 2012 Dec; 29(5):3162-8. PubMed ID: 22528516
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
6. NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma.
Song SP; Zhang SB; Liu R; Yao L; Hao YQ; Liao MM; Zhang YD; Li ZH
Med Oncol; 2012 Sep; 29(3):1879-85. PubMed ID: 22135002
[TBL] [Abstract][Full Text] [Related]
7. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
Yu L; Zhang J; Guo X; Li Z; Zhang P
Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
[TBL] [Abstract][Full Text] [Related]
9. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and Prognostic Value of Plasma CD24 Level in Hepatocellular Carcinoma.
Maimaitiming A; Zhou X; Ma X; Huang Y; Wang Q; Deng R; Ren Y; Chai X; Zhang P
J Invest Surg; 2020 Jul; 33(6):536-541. PubMed ID: 30543135
[No Abstract] [Full Text] [Related]
11. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
12. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
13. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
15. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
16. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma.
Huang B; Li H; Huang L; Luo C; Zhang Y
J Surg Res; 2015 Feb; 193(2):718-23. PubMed ID: 25439221
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
20. Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma.
You N; Tan Y; Zhou L; Huang X; Wang W; Wang L; Wu K; Mi N; Li J; Zheng L
Exp Cell Res; 2017 Sep; 358(2):217-226. PubMed ID: 28663060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]